Products for Research Use Only
RegisterLogin

MIP-1072

CAT: 0804-HY-129615Size: 1 EachDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-129615Size:1 Each
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
MIP-1072 is a small molecule specific prostate-specific membrane antigen (PSMA) inhibitor. MIP-1072 inhibits the glutamate carboxypeptidase activity of PSMA with an Ki value of 4.6 nM. MIP-1072 is promising for research of prostate cancer[1].
CAS Number
949575-20-6
UNSPSC
12352211
Target
PSMA
Type
Reference compound
Related Pathways
Immunology/Inflammation
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/mip-1072.html
Smiles
OC(CC[C@@H](C(O)=O)NC(N[C@H](C(O)=O)CCCCNCC1=CC=C(C=C1)I)=O)=O
Molecular Formula
C19H26IN3O7
Molecular Weight
535.33
References & Citations
[1]Hillier SM, et al. Preclinical evaluation of novel glutamate-urea-lysine analogues that target prostate-specific membrane antigen as molecular imaging pharmaceuticals for prostate cancer. Cancer Res. 2009 Sep 1;69 (17) :6932-40.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported

Related Products

CatalogName
HY-153895-01SLU-PP-1072
HY-168149Mip-IN-2
HY-149861Mip-IN-1
HY-123733MIP-1095
HY-123733A-01MIP-1095 (TFA)
HY-P7258-01MIP-2/CXCL2, Mouse
HY-P7266-01MIP-5/CCL15, Human
HY-P7265-01MIP-4/CCL18, Human
HY-P7256-01MIP-1 alpha/CCL3, Human
HY-P702526-01MIP-3 beta/CCL19, Human

Alternative Products

CatalogName
GTR19199944-01MIP-1072
GTR19213584-01SLU-PP-1072
323920-01MIP
081-87Signaltides™ - Neural Cell Adhesion Molecule 1 (1055-1072)
20-258SARS-CoV-2 (COVID-19) NSP3 (743 - 1072) Antibody
TR313961Cofilin 1 (CFL1) Human shRNA Plasmid Kit (Locus ID 1072)
GTR18911939SARS-CoV-2 (COVID-19) NSP3 (743 - 1072) Recombinant Protein
MBS7102343-01Recombinant Drosophila melanogaster Allatostatins MIP (Mip)
chm-358MIP 3
chm-322MIP 4

Popular Products